Global mRNA Synthesis Service Market Research Report 2024

Report ID: 1919323 | Published Date: Jan 2025 | No. of Page: 111 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global mRNA Synthesis Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 mRNA Vaccine Synthesis
        1.2.3 mRNA Drug Synthesis
    1.3 Market by Application
        1.3.1 Global mRNA Synthesis Service Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Clinical
        1.3.3 Research
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global mRNA Synthesis Service Market Perspective (2017-2028)
    2.2 mRNA Synthesis Service Growth Trends by Region
        2.2.1 mRNA Synthesis Service Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 mRNA Synthesis Service Historic Market Size by Region (2017-2022)
        2.2.3 mRNA Synthesis Service Forecasted Market Size by Region (2023-2028)
    2.3 mRNA Synthesis Service Market Dynamics
        2.3.1 mRNA Synthesis Service Industry Trends
        2.3.2 mRNA Synthesis Service Market Drivers
        2.3.3 mRNA Synthesis Service Market Challenges
        2.3.4 mRNA Synthesis Service Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top mRNA Synthesis Service Players by Revenue
        3.1.1 Global Top mRNA Synthesis Service Players by Revenue (2017-2022)
        3.1.2 Global mRNA Synthesis Service Revenue Market Share by Players (2017-2022)
    3.2 Global mRNA Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by mRNA Synthesis Service Revenue
    3.4 Global mRNA Synthesis Service Market Concentration Ratio
        3.4.1 Global mRNA Synthesis Service Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by mRNA Synthesis Service Revenue in 2021
    3.5 mRNA Synthesis Service Key Players Head office and Area Served
    3.6 Key Players mRNA Synthesis Service Product Solution and Service
    3.7 Date of Enter into mRNA Synthesis Service Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Synthesis Service Breakdown Data by Type
    4.1 Global mRNA Synthesis Service Historic Market Size by Type (2017-2022)
    4.2 Global mRNA Synthesis Service Forecasted Market Size by Type (2023-2028)
5 mRNA Synthesis Service Breakdown Data by Application
    5.1 Global mRNA Synthesis Service Historic Market Size by Application (2017-2022)
    5.2 Global mRNA Synthesis Service Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America mRNA Synthesis Service Market Size (2017-2028)
    6.2 North America mRNA Synthesis Service Market Size by Country (2017-2022)
    6.3 North America mRNA Synthesis Service Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe mRNA Synthesis Service Market Size (2017-2028)
    7.2 Europe mRNA Synthesis Service Market Size by Country (2017-2022)
    7.3 Europe mRNA Synthesis Service Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific mRNA Synthesis Service Market Size (2017-2028)
    8.2 Asia-Pacific mRNA Synthesis Service Market Size by Country (2017-2022)
    8.3 Asia-Pacific mRNA Synthesis Service Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America mRNA Synthesis Service Market Size (2017-2028)
    9.2 Latin America mRNA Synthesis Service Market Size by Country (2017-2022)
    9.3 Latin America mRNA Synthesis Service Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa mRNA Synthesis Service Market Size (2017-2028)
    10.2 Middle East & Africa mRNA Synthesis Service Market Size by Country (2017-2022)
    10.3 Middle East & Africa mRNA Synthesis Service Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 APExBIO
        11.1.1 APExBIO Company Detail
        11.1.2 APExBIO Business Overview
        11.1.3 APExBIO mRNA Synthesis Service Introduction
        11.1.4 APExBIO Revenue in mRNA Synthesis Service Business (2017-2022)
        11.1.5 APExBIO Recent Development
    11.2 Takeda Pharmaceuticals
        11.2.1 Takeda Pharmaceuticals Company Detail
        11.2.2 Takeda Pharmaceuticals Business Overview
        11.2.3 Takeda Pharmaceuticals mRNA Synthesis Service Introduction
        11.2.4 Takeda Pharmaceuticals Revenue in mRNA Synthesis Service Business (2017-2022)
        11.2.5 Takeda Pharmaceuticals Recent Development
    11.3 Tesla
        11.3.1 Tesla Company Detail
        11.3.2 Tesla Business Overview
        11.3.3 Tesla mRNA Synthesis Service Introduction
        11.3.4 Tesla Revenue in mRNA Synthesis Service Business (2017-2022)
        11.3.5 Tesla Recent Development
    11.4 Thermo Fisher Scientific
        11.4.1 Thermo Fisher Scientific Company Detail
        11.4.2 Thermo Fisher Scientific Business Overview
        11.4.3 Thermo Fisher Scientific mRNA Synthesis Service Introduction
        11.4.4 Thermo Fisher Scientific Revenue in mRNA Synthesis Service Business (2017-2022)
        11.4.5 Thermo Fisher Scientific Recent Development
    11.5 VGXI
        11.5.1 VGXI Company Detail
        11.5.2 VGXI Business Overview
        11.5.3 VGXI mRNA Synthesis Service Introduction
        11.5.4 VGXI Revenue in mRNA Synthesis Service Business (2017-2022)
        11.5.5 VGXI Recent Development
    11.6 WACKER Chemie
        11.6.1 WACKER Chemie Company Detail
        11.6.2 WACKER Chemie Business Overview
        11.6.3 WACKER Chemie mRNA Synthesis Service Introduction
        11.6.4 WACKER Chemie Revenue in mRNA Synthesis Service Business (2017-2022)
        11.6.5 WACKER Chemie Recent Development
    11.7 Siegfried
        11.7.1 Siegfried Company Detail
        11.7.2 Siegfried Business Overview
        11.7.3 Siegfried mRNA Synthesis Service Introduction
        11.7.4 Siegfried Revenue in mRNA Synthesis Service Business (2017-2022)
        11.7.5 Siegfried Recent Development
    11.8 ST Pharm
        11.8.1 ST Pharm Company Detail
        11.8.2 ST Pharm Business Overview
        11.8.3 ST Pharm mRNA Synthesis Service Introduction
        11.8.4 ST Pharm Revenue in mRNA Synthesis Service Business (2017-2022)
        11.8.5 ST Pharm Recent Development
    11.9 Novartis
        11.9.1 Novartis Company Detail
        11.9.2 Novartis Business Overview
        11.9.3 Novartis mRNA Synthesis Service Introduction
        11.9.4 Novartis Revenue in mRNA Synthesis Service Business (2017-2022)
        11.9.5 Novartis Recent Development
    11.10 Novo Nordisk
        11.10.1 Novo Nordisk Company Detail
        11.10.2 Novo Nordisk Business Overview
        11.10.3 Novo Nordisk mRNA Synthesis Service Introduction
        11.10.4 Novo Nordisk Revenue in mRNA Synthesis Service Business (2017-2022)
        11.10.5 Novo Nordisk Recent Development
    11.11 Pfizer
        11.11.1 Pfizer Company Detail
        11.11.2 Pfizer Business Overview
        11.11.3 Pfizer mRNA Synthesis Service Introduction
        11.11.4 Pfizer Revenue in mRNA Synthesis Service Business (2017-2022)
        11.11.5 Pfizer Recent Development
    11.12 LakePharma
        11.12.1 LakePharma Company Detail
        11.12.2 LakePharma Business Overview
        11.12.3 LakePharma mRNA Synthesis Service Introduction
        11.12.4 LakePharma Revenue in mRNA Synthesis Service Business (2017-2022)
        11.12.5 LakePharma Recent Development
    11.13 Lion TCR
        11.13.1 Lion TCR Company Detail
        11.13.2 Lion TCR Business Overview
        11.13.3 Lion TCR mRNA Synthesis Service Introduction
        11.13.4 Lion TCR Revenue in mRNA Synthesis Service Business (2017-2022)
        11.13.5 Lion TCR Recent Development
    11.14 Lonza
        11.14.1 Lonza Company Detail
        11.14.2 Lonza Business Overview
        11.14.3 Lonza mRNA Synthesis Service Introduction
        11.14.4 Lonza Revenue in mRNA Synthesis Service Business (2017-2022)
        11.14.5 Lonza Recent Development
    11.15 Merck
        11.15.1 Merck Company Detail
        11.15.2 Merck Business Overview
        11.15.3 Merck mRNA Synthesis Service Introduction
        11.15.4 Merck Revenue in mRNA Synthesis Service Business (2017-2022)
        11.15.5 Merck Recent Development
    11.16 GlaxoSmithKline
        11.16.1 GlaxoSmithKline Company Detail
        11.16.2 GlaxoSmithKline Business Overview
        11.16.3 GlaxoSmithKline mRNA Synthesis Service Introduction
        11.16.4 GlaxoSmithKline Revenue in mRNA Synthesis Service Business (2017-2022)
        11.16.5 GlaxoSmithKline Recent Development
    11.17 GenePharma
        11.17.1 GenePharma Company Detail
        11.17.2 GenePharma Business Overview
        11.17.3 GenePharma mRNA Synthesis Service Introduction
        11.17.4 GenePharma Revenue in mRNA Synthesis Service Business (2017-2022)
        11.17.5 GenePharma Recent Development
    11.18 Fareva
        11.18.1 Fareva Company Detail
        11.18.2 Fareva Business Overview
        11.18.3 Fareva mRNA Synthesis Service Introduction
        11.18.4 Fareva Revenue in mRNA Synthesis Service Business (2017-2022)
        11.18.5 Fareva Recent Development
    11.19 Fosun Pharma
        11.19.1 Fosun Pharma Company Detail
        11.19.2 Fosun Pharma Business Overview
        11.19.3 Fosun Pharma mRNA Synthesis Service Introduction
        11.19.4 Fosun Pharma Revenue in mRNA Synthesis Service Business (2017-2022)
        11.19.5 Fosun Pharma Recent Development
    11.20 GC Pharma
        11.20.1 GC Pharma Company Detail
        11.20.2 GC Pharma Business Overview
        11.20.3 GC Pharma mRNA Synthesis Service Introduction
        11.20.4 GC Pharma Revenue in mRNA Synthesis Service Business (2017-2022)
        11.20.5 GC Pharma Recent Development
    11.21 Syneos Health
        11.21.1 Syneos Health Company Detail
        11.21.2 Syneos Health Business Overview
        11.21.3 Syneos Health mRNA Synthesis Service Introduction
        11.21.4 Syneos Health Revenue in mRNA Synthesis Service Business (2017-2022)
        11.21.5 Syneos Health Recent Development
    11.22 Bayer
        11.22.1 Bayer Company Detail
        11.22.2 Bayer Business Overview
        11.22.3 Bayer mRNA Synthesis Service Introduction
        11.22.4 Bayer Revenue in mRNA Synthesis Service Business (2017-2022)
        11.22.5 Bayer Recent Development
    11.23 Beijing Tricision Biotherapeutics
        11.23.1 Beijing Tricision Biotherapeutics Company Detail
        11.23.2 Beijing Tricision Biotherapeutics Business Overview
        11.23.3 Beijing Tricision Biotherapeutics mRNA Synthesis Service Introduction
        11.23.4 Beijing Tricision Biotherapeutics Revenue in mRNA Synthesis Service Business (2017-2022)
        11.23.5 Beijing Tricision Biotherapeutics Recent Development
    11.24 Cellerna
        11.24.1 Cellerna Company Detail
        11.24.2 Cellerna Business Overview
        11.24.3 Cellerna mRNA Synthesis Service Introduction
        11.24.4 Cellerna Revenue in mRNA Synthesis Service Business (2017-2022)
        11.24.5 Cellerna Recent Development
    11.25 Eli Lilly
        11.25.1 Eli Lilly Company Detail
        11.25.2 Eli Lilly Business Overview
        11.25.3 Eli Lilly mRNA Synthesis Service Introduction
        11.25.4 Eli Lilly Revenue in mRNA Synthesis Service Business (2017-2022)
        11.25.5 Eli Lilly Recent Development
    11.26 CMC Pharmaceuticals
        11.26.1 CMC Pharmaceuticals Company Detail
        11.26.2 CMC Pharmaceuticals Business Overview
        11.26.3 CMC Pharmaceuticals mRNA Synthesis Service Introduction
        11.26.4 CMC Pharmaceuticals Revenue in mRNA Synthesis Service Business (2017-2022)
        11.26.5 CMC Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global mRNA Synthesis Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of mRNA Vaccine Synthesis
    Table 3. Key Players of mRNA Drug Synthesis
    Table 4. Global mRNA Synthesis Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global mRNA Synthesis Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global mRNA Synthesis Service Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global mRNA Synthesis Service Market Share by Region (2017-2022)
    Table 8. Global mRNA Synthesis Service Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global mRNA Synthesis Service Market Share by Region (2023-2028)
    Table 10. mRNA Synthesis Service Market Trends
    Table 11. mRNA Synthesis Service Market Drivers
    Table 12. mRNA Synthesis Service Market Challenges
    Table 13. mRNA Synthesis Service Market Restraints
    Table 14. Global mRNA Synthesis Service Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global mRNA Synthesis Service Market Share by Players (2017-2022)
    Table 16. Global Top mRNA Synthesis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Synthesis Service as of 2021)
    Table 17. Ranking of Global Top mRNA Synthesis Service Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by mRNA Synthesis Service Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players mRNA Synthesis Service Product Solution and Service
    Table 21. Date of Enter into mRNA Synthesis Service Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global mRNA Synthesis Service Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global mRNA Synthesis Service Revenue Market Share by Type (2017-2022)
    Table 25. Global mRNA Synthesis Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global mRNA Synthesis Service Revenue Market Share by Type (2023-2028)
    Table 27. Global mRNA Synthesis Service Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global mRNA Synthesis Service Revenue Market Share by Application (2017-2022)
    Table 29. Global mRNA Synthesis Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global mRNA Synthesis Service Revenue Market Share by Application (2023-2028)
    Table 31. North America mRNA Synthesis Service Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America mRNA Synthesis Service Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe mRNA Synthesis Service Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe mRNA Synthesis Service Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific mRNA Synthesis Service Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific mRNA Synthesis Service Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America mRNA Synthesis Service Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America mRNA Synthesis Service Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa mRNA Synthesis Service Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa mRNA Synthesis Service Market Size by Country (2023-2028) & (US$ Million)
    Table 41. APExBIO Company Detail
    Table 42. APExBIO Business Overview
    Table 43. APExBIO mRNA Synthesis Service Product
    Table 44. APExBIO Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 45. APExBIO Recent Development
    Table 46. Takeda Pharmaceuticals Company Detail
    Table 47. Takeda Pharmaceuticals Business Overview
    Table 48. Takeda Pharmaceuticals mRNA Synthesis Service Product
    Table 49. Takeda Pharmaceuticals Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 50. Takeda Pharmaceuticals Recent Development
    Table 51. Tesla Company Detail
    Table 52. Tesla Business Overview
    Table 53. Tesla mRNA Synthesis Service Product
    Table 54. Tesla Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 55. Tesla Recent Development
    Table 56. Thermo Fisher Scientific Company Detail
    Table 57. Thermo Fisher Scientific Business Overview
    Table 58. Thermo Fisher Scientific mRNA Synthesis Service Product
    Table 59. Thermo Fisher Scientific Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 60. Thermo Fisher Scientific Recent Development
    Table 61. VGXI Company Detail
    Table 62. VGXI Business Overview
    Table 63. VGXI mRNA Synthesis Service Product
    Table 64. VGXI Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 65. VGXI Recent Development
    Table 66. WACKER Chemie Company Detail
    Table 67. WACKER Chemie Business Overview
    Table 68. WACKER Chemie mRNA Synthesis Service Product
    Table 69. WACKER Chemie Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 70. WACKER Chemie Recent Development
    Table 71. Siegfried Company Detail
    Table 72. Siegfried Business Overview
    Table 73. Siegfried mRNA Synthesis Service Product
    Table 74. Siegfried Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 75. Siegfried Recent Development
    Table 76. ST Pharm Company Detail
    Table 77. ST Pharm Business Overview
    Table 78. ST Pharm mRNA Synthesis Service Product
    Table 79. ST Pharm Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 80. ST Pharm Recent Development
    Table 81. Novartis Company Detail
    Table 82. Novartis Business Overview
    Table 83. Novartis mRNA Synthesis Service Product
    Table 84. Novartis Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 85. Novartis Recent Development
    Table 86. Novo Nordisk Company Detail
    Table 87. Novo Nordisk Business Overview
    Table 88. Novo Nordisk mRNA Synthesis Service Product
    Table 89. Novo Nordisk Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 90. Novo Nordisk Recent Development
    Table 91. Pfizer Company Detail
    Table 92. Pfizer Business Overview
    Table 93. Pfizer mRNA Synthesis ServiceProduct
    Table 94. Pfizer Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 95. Pfizer Recent Development
    Table 96. LakePharma Company Detail
    Table 97. LakePharma Business Overview
    Table 98. LakePharma mRNA Synthesis ServiceProduct
    Table 99. LakePharma Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 100. LakePharma Recent Development
    Table 101. Lion TCR Company Detail
    Table 102. Lion TCR Business Overview
    Table 103. Lion TCR mRNA Synthesis ServiceProduct
    Table 104. Lion TCR Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 105. Lion TCR Recent Development
    Table 106. Lonza Company Detail
    Table 107. Lonza Business Overview
    Table 108. Lonza mRNA Synthesis ServiceProduct
    Table 109. Lonza Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 110. Lonza Recent Development
    Table 111. Merck Company Detail
    Table 112. Merck Business Overview
    Table 113. Merck mRNA Synthesis ServiceProduct
    Table 114. Merck Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 115. Merck Recent Development
    Table 116. GlaxoSmithKline Company Detail
    Table 117. GlaxoSmithKline Business Overview
    Table 118. GlaxoSmithKline mRNA Synthesis ServiceProduct
    Table 119. GlaxoSmithKline Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 120. GlaxoSmithKline Recent Development
    Table 121. GenePharma Company Detail
    Table 122. GenePharma Business Overview
    Table 123. GenePharma mRNA Synthesis ServiceProduct
    Table 124. GenePharma Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 125. GenePharma Recent Development
    Table 126. Fareva Company Detail
    Table 127. Fareva Business Overview
    Table 128. Fareva mRNA Synthesis ServiceProduct
    Table 129. Fareva Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 130. Fareva Recent Development
    Table 131. Fosun Pharma Company Detail
    Table 132. Fosun Pharma Business Overview
    Table 133. Fosun Pharma mRNA Synthesis ServiceProduct
    Table 134. Fosun Pharma Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 135. Fosun Pharma Recent Development
    Table 136. GC Pharma Company Detail
    Table 137. GC Pharma Business Overview
    Table 138. GC Pharma mRNA Synthesis ServiceProduct
    Table 139. GC Pharma Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 140. GC Pharma Recent Development
    Table 141. Syneos Health Company Detail
    Table 142. Syneos Health Business Overview
    Table 143. Syneos Health mRNA Synthesis ServiceProduct
    Table 144. Syneos Health Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 145. Syneos Health Recent Development
    Table 146. Bayer Company Detail
    Table 147. Bayer Business Overview
    Table 148. Bayer mRNA Synthesis ServiceProduct
    Table 149. Bayer Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 150. Bayer Recent Development
    Table 151. Beijing Tricision Biotherapeutics Company Detail
    Table 152. Beijing Tricision Biotherapeutics Business Overview
    Table 153. Beijing Tricision Biotherapeutics mRNA Synthesis ServiceProduct
    Table 154. Beijing Tricision Biotherapeutics Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 155. Beijing Tricision Biotherapeutics Recent Development
    Table 156. Cellerna Company Detail
    Table 157. Cellerna Business Overview
    Table 158. Cellerna mRNA Synthesis ServiceProduct
    Table 159. Cellerna Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 160. Cellerna Recent Development
    Table 161. Eli Lilly Company Detail
    Table 162. Eli Lilly Business Overview
    Table 163. Eli Lilly mRNA Synthesis ServiceProduct
    Table 164. Eli Lilly Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 165. Eli Lilly Recent Development
    Table 166. CMC Pharmaceuticals Company Detail
    Table 167. CMC Pharmaceuticals Business Overview
    Table 168. CMC Pharmaceuticals mRNA Synthesis ServiceProduct
    Table 169. CMC Pharmaceuticals Revenue in mRNA Synthesis Service Business (2017-2022) & (US$ Million)
    Table 170. CMC Pharmaceuticals Recent Development
    Table 171. Research Programs/Design for This Report
    Table 172. Key Data Information from Secondary Sources
    Table 173. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global mRNA Synthesis Service Market Share by Type: 2021 VS 2028
    Figure 2. mRNA Vaccine Synthesis Features
    Figure 3. mRNA Drug Synthesis Features
    Figure 4. Global mRNA Synthesis Service Market Share by Application in 2021 & 2028
    Figure 5. Clinical Case Studies
    Figure 6. Research Case Studies
    Figure 7. Others Case Studies
    Figure 8. mRNA Synthesis Service Report Years Considered
    Figure 9. Global mRNA Synthesis Service Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global mRNA Synthesis Service Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global mRNA Synthesis Service Market Share by Region: 2021 VS 2028
    Figure 12. Global mRNA Synthesis Service Market Share by Players in 2021
    Figure 13. Global Top mRNA Synthesis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Synthesis Service as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by mRNA Synthesis Service Revenue in 2021
    Figure 15. North America mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America mRNA Synthesis Service Market Share by Country (2017-2028)
    Figure 17. United States mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe mRNA Synthesis Service Market Share by Country (2017-2028)
    Figure 21. Germany mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific mRNA Synthesis Service Market Share by Region (2017-2028)
    Figure 29. China mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America mRNA Synthesis Service Market Share by Country (2017-2028)
    Figure 37. Mexico mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa mRNA Synthesis Service Market Share by Country (2017-2028)
    Figure 41. Turkey mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia mRNA Synthesis Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. APExBIO Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 44. Takeda Pharmaceuticals Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 45. Tesla Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 46. Thermo Fisher Scientific Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 47. VGXI Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 48. WACKER Chemie Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 49. Siegfried Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 50. ST Pharm Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 51. Novartis Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 52. Novo Nordisk Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 53. Pfizer Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 54. LakePharma Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 55. Lion TCR Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 56. Lonza Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 57. Merck Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 59. GenePharma Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 60. Fareva Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 61. Fosun Pharma Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 62. GC Pharma Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 63. Syneos Health Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 64. Bayer Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 65. Beijing Tricision Biotherapeutics Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 66. Cellerna Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 67. Eli Lilly Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 68. CMC Pharmaceuticals Revenue Growth Rate in mRNA Synthesis Service Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
APExBIO
Takeda Pharmaceuticals
Tesla
Thermo Fisher Scientific
VGXI
WACKER Chemie
Siegfried
ST Pharm
Novartis
Novo Nordisk
Pfizer
LakePharma
Lion TCR
Lonza
Merck
GlaxoSmithKline
GenePharma
Fareva
Fosun Pharma
GC Pharma
Syneos Health
Bayer
Beijing Tricision Biotherapeutics
Cellerna
Eli Lilly
CMC Pharmaceuticals
Frequently Asked Questions
mRNA Synthesis Service report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
mRNA Synthesis Service report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
mRNA Synthesis Service report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports